TLDR:
- Frazier Life Sciences has added Simpson as a venture partner.
- Simpson has experience building 11 companies that have been acquired or gone public.
Frazier Life Sciences has announced the addition of Simpson as a venture partner. Simpson brings a wealth of experience, having helped build 11 companies that have either been acquired or gone public. Most recently, Simpson served as the CEO of Icosavax, which went public and was later acquired by AstraZeneca.
This move is significant for Frazier Life Sciences as they continue to strengthen their team with experienced industry professionals. Simpson’s track record of successful company building and navigating acquisitions will prove valuable as the firm looks to identify and invest in promising life sciences companies.
Overall, Simpson’s addition to Frazier Life Sciences as a venture partner underscores the firm’s commitment to driving innovation and growth in the life sciences sector through strategic investments and partnerships.
